Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things - 2What's your biological age? Experts explain the benefits and risks of at-home tests
- 3An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
- 4South Korea president says Iran war shows the need to ditch ‘extremely risky’ fossil fuels
- 5Glamour Shots once ruled the mall. I went to one of the last ones standing.
- The Meaning of Breaking the Pen's Nib in Death penalties
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Saturn shines with the waxing moon at sunset on Nov. 29
- I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
- The Developing Nearby Food Development and Its Advantages
- Find the Force of The ability to understand anyone on a deeper level: Improving Mindfulness and Connections
- Share your pick for the riding area that characterizes your surf undertakings!
- Australia Cracks Down on Gambling Ads as Prediction Markets Like Polymarket Remain Blocked
- Tragedy in Minnesota, vaccine news, Snoop's game call: Week in review
